Interleukin-18 regulates pathological intraocular neovascularization

Journal of Leukocyte Biology

Volumn 81, Issue 4, 2007, Pages 1012-1021

  Qiao, Hong ^a   Sonoda, Koh Hei ^a   Ikeda, Yasuhiro ^a   Yoshimura, Takeru ^a   Hijioka, Kuniaki ^a   Jo, Young Joon ^a   Sassa, Yukio ^a   Tsutsumi Miyahara, Chikako ^a   Hata, Yasuaki ^a   Akira, Shizuo ^b   Ishibashi, Tatsuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Cytokine; Inflammation; Rodent

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; OXYGEN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; GENE EXPRESSION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OXYGEN CONCENTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA; RETINA NEOVASCULARIZATION; RETINOPATHY;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON TYPE II; INTERLEUKIN-18; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXYGEN; RETINA; RETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS; RODENTIA;

EID: 33947652164     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0506342     Document Type: Article

References (47)

1. Hutcheson, K. A. (2003) Retinopathy of prematurity. Curr. Opin. Ophthalmol. 14, 286-290.
2. Smith, L. E., Wesolowski, E., McLellan, A., Kostyk, S. K., D'Amato, R., Sullivan, R., D'Amore, P. A. (1994) Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35, 101-111.
3. Nakamura, K., Okamura, H., Wada, M., Nagata, K., Tamura, T. (1989) Endotoxin-induced serum factor that stimulates γ interferon production. Infect. Immun. 57, 590-595.
4. Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., Akita, K., Namba, M., Tanabe, F., Konishi, K., Fukuda, S., Kurimoto, M. (1995) Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378, 88-91.
5. Ushio, S., Namba, M., Okura, T., Hattori, K., Nukada, Y., Akita, K., Tanabe, F., Konishi, K., Micallef, M., Fujii, M., Torigoe, K., Tanimoto, T., Fukuda, S., Ideda, M., Okamura, H., Kurimoto, M. (1996) Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. 156, 4274-4279.
6. Dinarello, C. A. (1999) IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 103, 11-24.
7. Kohno, K., Kataoka, J., Ohtsuki, T., Suemoto, Y., Okamoto, I., Usui, M., Ikeda, M., Kurimoto, M. (1997) IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 158, 1541-1550.
8. Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N., Kishimoto, T., Okamura, H., Nakanishi, K., Akira, S. (1998) Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8, 383-390.
9. Coughlin, C. M., Salhany, K. E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A. E., Hunter, C. A., Fox, J. C., Trinchieri, G., Lee, W. M. (1998) Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest. 101, 1441-1452.
10. Cao, R., Farnebo, J., Kurimoto, M., Cao, Y. (1999) Interleukin-18 acts as an angiogenesis and tumor suppressor. FASEB J. 13, 2195-2202.
11. Kim, B., Lee, S., Suvas, S., Rouse, B. T. (2005) Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects. J. Immunol. 175, 509-516.
12. Kim, J., Kim, C., Kim, T. S., Bang, S. I., Yang, Y., Park, H., Cho, D. (2006) IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. Biochem. Biophys. Res. Commun. 344, 1284-1289.
13. Park, C. C., Morel, J. C., Amin, M. A., Connors, M. A., Harlow, L. A., Koch, A. E. (2001) Evidence of IL-18 as a novel angiogenic mediator. J. Immunol. 167, 1644-1653.
14. Cho, M. L., Jung, Y. O., Moon, Y. M., Min, S. Y., Yoon, C. H., Lee, S. H., Park, S. H., Cho, C. S., Jue, D. M., Kim, H. Y. (2006) Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol. Lett. 103, 159-166.
15. Jiang, H. R., Wei, X., Niedbala, W., Lumsden, L., Liew, F. Y., Forrester, J. V. (2001) IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice. Invest. Ophthalmol. Vis. Sci. 42, 177-182.
16. Novick, D., Kim, S. H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., Rubinstein, M. (1999) Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10, 127-136.
17. Kim, S. H., Eisenstein, M., Reznikov, L., Fantuzzi, G., Novick, D., Rubinstein, M., Dinarello, C. A. (2000) Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc. Natl. Acad. Sci. USA 97, 1190-1195.
18. Higgins, R. D., Yu, K., Sanders, R. J., Nandgaonkar, B. N., Rotschild, T., Rifkin, D. B. (1999) Diltiazem reduces retinal neovascularization in a mouse model of oxygen-induced retinopathy. Curr. Eye Res. 18, 20-27.
19. Banda, N. K., Vondracek, A., Kraus, D., Dinarello, C. A., Kim, S. H., Bendele, A., Senaldi, G., Arend, W. P. (2003) Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. J. Immunol. 170, 2100-2105.
20. Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., Smith, L. E. (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92, 905-909.
21. Qiao, H., Sonoda, K. H., Sassa, Y., Hisatomi, T., Yoshikawa, H., Ikeda, Y., Murata, T., Akira, S., Ishibashi, T. (2004) Abnormal retinal vascular development in IL-18 knockout mice. Lab. Invest. 84, 973-980.
22. Shweiki, D., Itin, A., Soffer, D., Keshet, E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.
23. Pe'er, J., Shweiki, D., Itin, A., Hemo, I., Gnessin, H., Keshet, E. (1995) Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab. Invest. 72, 638-645.
24. Smith, L. E., Kopchick, J. J., Chen, W., Knapp, J., Kinose, F., Daley, D., Foley, E., Smith, R. G., Schaeffer, J. M. (1997) Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276, 1706-1709.
25. Mallat, Z., Silvestre, J. S., Le Ricousse-Roussanne, S., Lecomte-Raclet, L., Corbaz, A., Clergue, M., Duriez, M., Barateau, V., Akira, S., Tedgui, A., Tobelem, G., Chvatchko, Y., Levy, B. I. (2002) Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb. Circ. Res. 91, 441-448.
26. Canetti, C. A., Leung, B. P., Culshaw, S., McInnes, I. B., Cunha, F. Q., Liew, F. Y. (2003) IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-{α} and leukotriene B4. J. Immunol. 171, 1009-1015.
27. Coughlin, C. M., Salhany, K. E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A. E., Hunter, C. A., Fox, J. C., Trinchieri, G., Lee, W. M. (1998) Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest. 101, 1441-1452.
28. Kakuta, S., Tagawa, Y., Shibata, S., Nanno, M., Iwakura, Y. (2002) Inhibition of B16 melanoma experimental metastasis by interferon-γ through direct inhibition of cell proliferation and activation of antitumour host mechanisms. Immunology 105, 92-100.
29. Proost, P., Schutyser, E., Menten, P., Struyf, S., Wuyts, A., Opdenakker, G., Detheux, M., Parmentier, M., Durinx, C., Lambeir, A. M., Neyts, J., Liekens, S., Maudgal, P. C., Billiau, A., VanDamme, J. (2001) Aminoterminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98, 3554-3561.
30. Park, C. C., Morel, J. C., Amin, M. A., Connors, M. A., Harlow, L. A., Koch, A. E. (2001) Evidence of IL-18 as a novel angiogenic mediator. J. Immunol. 167, 1644-1653.
31. Plate, K. H., Breier, G., Welch, H. A., Risau, W. (1992) Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359, 845-848.
32. Shweiki, D., Itin, A., Soffer, D., Keshet, E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.
33. Pe'er, J., Shweiki, D., Itin, A., Hemo, I., Gnessin, H., Keshet, E. (1995) Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab. Invest. 72, 638-645.
34. Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., Smith, L. E. (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92, 905-909.
35. Smith, L. E., Kopchick, J. J., Chen, W., Knapp, J., Kinose, F., Daley, D., Foley, E., Smith, R. G., Schaeffer, J. M. (1997) Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276, 1706-1709.
36. Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Amano, S., Ogura, Y., Hida, T., Oguchi, Y., Ambati, J., Miller, J. W., Gragoudas, E. S., Ng, Y. S., D'Amore, P. A., Shima, D. T., Adamis, A. P. (2003) VEGF164-mediated inflammation is required for pathological, but not physiological, ischemiainduced retinal neovascularization. J. Exp. Med. 198, 483-489.
37. Saint-Geniez, M., D'Amore, P. A. (2004) Development and pathology of the hyaloid, choroidal and retinal vasculature. Int. J. Dev. Biol. 48, 1045-1058.
38. Wang, S., Wu, Z., Sorenson, C. M., Lawler, J., Sheibani, N. (2003) Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration. Dev. Dyn. 228, 630-642.
39. May, C. A., Ohlmann, A. V., Hammes, H., Spandau, U. H. (2006) Proteins with an endostatin-like domain in a mouse model of oxygen-induced retinopathy. Exp. Eye Res. 82, 341-388.
40. Kim, J., Kim, C., Kim, T. S., Bang, S. I., Yang, Y., Park, H., Cho, D. (2006) IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. Biochem. Biophys. Res. Commun. 344, 1284-1289.
41. Jablonska, E., Puzewska, W., Grabowska, Z., Jablonski, J., Talarek, L. (2005) VEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancer. Cytokine 30, 93-99.
42. Okano, F., Yamada, K. (2000) Canine interleukin-18 induces apoptosis and enhances Fas ligand mRNA expression in a canine carcinoma cell line. Anticancer Res. 20, 3411-3415.
43. Faggioni, R., Cattley, R. C., Guo, J., Flores, S., Brown, H., Qi, M., Yin, S., Hill, D., Scully, S., Chen, C., Brankow, D., Lewis, J., Baikalov, C., Yamane, H., Meng, t., Martin, F., Hu, S., Boone, T., Senaldi, G. (2001) IL-18-binding protein protects against lipopolysaccharide-induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice. J. Immunol. 167, 5913-5920.
44. Tsutsui, H., Matsui, K., Okamura, H., Nakanishi, K. (2000) Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol. Rev. 174, 192-209.
45. Barreiro, R., Schadlu, R., Herndon, J., Kaplan, H. J., Ferguson, T. A. (2003) The Role of Fas-FasL in the development and treatment of ischemic retinopathy. Invest. Ophthalmol. Vis. Sci. 44, 1282-1286.
46. Davies, M. H., Eubanks, J. P., Powers, M. R. (2003) Increased retinal neovascularization in Fas ligand-deficient mice. Invest. Ophthalmol. Vis. Sci. 44, 3202-3210.
47. Volpert, O. V., Zaichuk, T., Zhou, W., Reiher, F., Ferguson, T. A., Stuart, P. M., Amin, M., Bouck, N. P. (2002) Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat. Med. 8, 349-357.